JPWO2023149548A5 - - Google Patents

Info

Publication number
JPWO2023149548A5
JPWO2023149548A5 JP2023578643A JP2023578643A JPWO2023149548A5 JP WO2023149548 A5 JPWO2023149548 A5 JP WO2023149548A5 JP 2023578643 A JP2023578643 A JP 2023578643A JP 2023578643 A JP2023578643 A JP 2023578643A JP WO2023149548 A5 JPWO2023149548 A5 JP WO2023149548A5
Authority
JP
Japan
Prior art keywords
carbon atoms
electron
pharmaceutical composition
alkyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023578643A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2023149548A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2023/003580 external-priority patent/WO2023149548A1/ja
Publication of JPWO2023149548A1 publication Critical patent/JPWO2023149548A1/ja
Publication of JPWO2023149548A5 publication Critical patent/JPWO2023149548A5/ja
Pending legal-status Critical Current

Links

JP2023578643A 2022-02-03 2023-02-03 Pending JPWO2023149548A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2022015848 2022-02-03
PCT/JP2023/003580 WO2023149548A1 (ja) 2022-02-03 2023-02-03 新規医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2023149548A1 JPWO2023149548A1 (https=) 2023-08-10
JPWO2023149548A5 true JPWO2023149548A5 (https=) 2026-02-09

Family

ID=87552610

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023578643A Pending JPWO2023149548A1 (https=) 2022-02-03 2023-02-03

Country Status (2)

Country Link
JP (1) JPWO2023149548A1 (https=)
WO (1) WO2023149548A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003258491A1 (en) * 2002-09-05 2004-03-29 Neurosearch A/S Amide derivatives and their use as chloride channel blockers
US8188131B2 (en) * 2008-02-07 2012-05-29 Massachusetts Eye & Ear Infirmary Compounds that enhance Atoh1 expression
EP3694502B1 (en) * 2017-10-09 2023-08-02 Merck Sharp & Dohme LLC Novel substituted cyclobutylbenzene compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
JP2021536458A (ja) * 2018-09-04 2021-12-27 マジェンタ セラピューティクス インコーポレイテッドMagenta Therapeutics, Inc. アリール炭化水素レセプター・アンタゴニスト及び使用方法

Similar Documents

Publication Publication Date Title
JP4959900B2 (ja) 抗ウイルスピリミジンヌクレオシド類
ES2687985T3 (es) Combinación de regorafenib y ácido acetilsalicílico para el tratamiento del cáncer colorrectal
JP2020007311A5 (https=)
JP2005523922A5 (https=)
JP2007505933A5 (https=)
JP2017537158A5 (https=)
JP2007511504A5 (https=)
JP2005533748A5 (https=)
JP2013532668A5 (https=)
WO2016082713A1 (zh) 2-氨基嘧啶类化合物及其药物组合物和应用
JP2019527724A5 (https=)
JP2019507114A5 (https=)
JP2021102643A5 (https=)
AU2008216106C1 (en) Cancer treatment method
JP2016525104A5 (https=)
US20180044368A1 (en) Gemcitabine derivatives
JP2006503805A5 (https=)
JP2020534266A5 (https=)
JPWO2023149549A5 (https=)
WO2016205460A4 (en) Polycyclic derivatives targeting ral gtpases and their therapeutical applications
JPWO2023149548A5 (https=)
RU2010136324A (ru) Циклические индол-3-карбоксамиды, их получение и их применение в качестве лекарственных препаратов
US20130225638A1 (en) Imidazole derivatives and preparation method and use thereof
CN108473449B (zh) 一种作为吲哚胺-2,3-双加氧酶抑制剂的砜脒及其制备方法和用途
JP2025517442A5 (https=)